Paysign, Inc. (NASDAQ:PAYS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Paysign, Inc. (NASDAQ:PAYS) has earned a consensus rating of “Moderate Buy” from the five ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $8.5625.

PAYS has been the topic of several research analyst reports. DA Davidson reissued a “buy” rating and issued a $9.00 price objective on shares of Paysign in a research report on Thursday, November 13th. Weiss Ratings restated a “hold (c)” rating on shares of Paysign in a research note on Wednesday, October 8th. Finally, Wall Street Zen upgraded shares of Paysign from a “hold” rating to a “buy” rating in a research note on Saturday, November 15th.

Paysign Stock Performance

Paysign stock opened at $5.19 on Wednesday. Paysign has a 52-week low of $1.80 and a 52-week high of $8.88. The stock has a market capitalization of $285.66 million, a price-to-earnings ratio of 39.93 and a beta of 0.93. The stock’s 50 day moving average price is $5.41 and its two-hundred day moving average price is $5.82.

Paysign (NASDAQ:PAYS) last released its quarterly earnings data on Wednesday, November 12th. The company reported $0.04 EPS for the quarter, meeting the consensus estimate of $0.04. Paysign had a return on equity of 19.18% and a net margin of 10.10%.The firm had revenue of $21.60 million during the quarter, compared to the consensus estimate of $19.92 million. Paysign has set its FY 2025 guidance at 0.120-0.130 EPS. On average, equities research analysts forecast that Paysign will post 0.21 EPS for the current year.

Institutional Investors Weigh In On Paysign

Several hedge funds have recently bought and sold shares of PAYS. Jacobs Levy Equity Management Inc. bought a new position in Paysign during the third quarter valued at approximately $1,640,000. PharVision Advisers LLC purchased a new stake in Paysign in the third quarter worth $327,000. Verition Fund Management LLC bought a new stake in Paysign in the third quarter valued at $207,000. Quarry LP purchased a new position in Paysign during the 3rd quarter valued at $54,000. Finally, Qube Research & Technologies Ltd purchased a new stake in Paysign in the third quarter worth about $67,000. 25.89% of the stock is currently owned by institutional investors.

About Paysign

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.